Zobrazeno 1 - 10
of 72
pro vyhledávání: '"Jan Krhut"'
Autor:
Katerina Rysankova, Pavla Hanzlikova, Vladimir Zidlik, Adela Vrtkova, Maryna Slisarenko, Jozef Skarda, Michal Grepl, Jan Krhut
Publikováno v:
Biomedical Papers, Vol 167, Iss 1, Pp 85-90 (2023)
Aims. Currently, the only method used to differentiate between MIBC and NMIBC is transurethral resection of the bladder tumour (TURBT). Magnetic resonance and Vesical Imaging-Reporting and Data System (VI-RADS) would allow for discrimination between
Externí odkaz:
https://doaj.org/article/34a50c50e82f4feebc26d4e752a6e99a
Publikováno v:
International Neurourology Journal, Vol 24, Iss 1, Pp 59-65 (2020)
Purpose To evaluate intravesical loss of onabolunumtoxinA (onaBTA) during endoscopic injection into the bladder wall for treatment of neurogenic detrusor overactivity (NDO). The intraluminal loss of onaBTA cannot be determined directly, therefore we
Externí odkaz:
https://doaj.org/article/8ecabf904a174f1599aedf069b9e4a00
Autor:
Travis K. Mann-Gow, Benjamin J. King, Ahmed El-Ghannam, Christine Knabe-Ducheyne, Masatoshi Kida, Ole M. Dall, Jan Krhut, Peter Zvara
Publikováno v:
Advances in Urology, Vol 2016 (2016)
Objectives. To test the physical properties and host response to the bioceramic particles, silica-calcium phosphate (SCPC10) and Cristobalite, in a rat animal model and compare their biocompatibility to the current clinically utilized urethral bulkin
Externí odkaz:
https://doaj.org/article/e7de61f202fd4d8ba1669f74d339f698
Publikováno v:
World Journal of Urology, 41(6), 1629-1634. Springer-Verlag
Purpose: The aim of this prospective 12-month follow-up study is to evaluate the persistence of the treatment effect achieved during the initial course of peroneal electrical Transcutaneous NeuroModulation (peroneal eTNM®) in patients with overactiv
Autor:
Jan Krhut, Michal Rejchrt, Martin Slovak, Roman V. Dvorak, Lukas Peter, Bertil F. M. Blok, Peter Zvara
Publikováno v:
Journal of Urology, 209(4), 734-741. Elsevier Inc.
Purpose: We investigated the safety and efficacy of peroneal electrical transcutaneous neuromodulation using the URIS neuromodulation system in a home-based setting in comparison with standard treatment using solifenacin in treatment-naïve female pa
Autor:
Jan Krhut, Jaroslav Tintěra, Michal Rejchrt, Barbora Skugarevská, Roman Zachoval, Peter Zvara, Bertil F. M. Blok
Publikováno v:
Neurourology and Urodynamics. Wiley-Liss Inc.
Objectives: To compare brain responses to peroneal electrical transcutaneous neuromodulation (peroneal eTNM®) and transcutaneous tibial nerve stimulation (TTNS), two methods for treating overactive bladder (OAB), using functional magnetic resonance
Publikováno v:
Krhut, J, Skugarevská, B, Míka, D, Lund, L & Zvara, P 2022, ' Clinical Utility of β 3-Adrenoreceptor Agonists for the Treatment of Overactive Bladder : A Review of the Evidence and Current Recommendations ', Research and Reports in Urology, vol. 14, pp. 167-175 . https://doi.org/10.2147/RRU.S309144
This nonsystematic review provides a summary of current evidence on the use of β3-adrenoreceptor agonists (β3-ARAs) for the treatment for lower urinary tract symptoms. Soon after their discovery in 1989, β3-ARs were identified as a predominant adr
Publikováno v:
Urologia Internationalis. 106:658-663
Introduction: The aim of this study was to determine whether peroneal electrical Transcutaneous NeuroModulation (peroneal eTNM®) using the URIS® neuromodulation system can be used in individuals with refractory overactive bladder (OAB). Methods: Ei
Autor:
Jan Krhut, Jaroslav Tintěra, Michal Rejchrt, Barbora Skugarevska, Michal Grepl, Roman Zachoval, Peter Zvara, Bertil F.M. Blok
Publikováno v:
Neuromodulation. Wiley-Blackwell Publishing Ltd
Objectives: In this study, we aimed to investigate whether peroneal electrical Transcutaneous Neuromodulation invented for overactive bladder (OAB) treatment elicits activation in brain regions involved in neural regulation of the lower urinary tract
Publikováno v:
International Urogynecology Journal.
The aim of this prospective, open-label, multicenter, noncomparative study was to evaluate the efficacy and safety of peroneal electrical transcutaneous neuromodulation (peroneal eTNMThe patients were treated with daily peroneal eTNMIn total, 40 subj